{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-22",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Ongoing",
      "city": "Minneapolis",
      "state": "MN",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "93829",
      "recalling_firm": "IntegraDose Compounding Services LLC",
      "address_1": "719 Kasota Ave Se",
      "address_2": "N/A",
      "postal_code": "55414-2842",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "MN only",
      "recall_number": "D-0258-2024",
      "product_description": "Vasopressin 2 Unit/2 mL in 0.9% Sodium Chloride, 2 mL per syringe, Rx Only, 719 Kasota Ave SE, Minneapolis, MN. NDC 71139-0190-1",
      "product_quantity": "281 syringes",
      "reason_for_recall": "Subpotent Drug",
      "recall_initiation_date": "20240112",
      "center_classification_date": "20240122",
      "report_date": "20240131",
      "code_info": "Lot #: 20230921VAS-2, Exp. Date 03/19/2024"
    }
  ]
}